Garlic supplement potency labeling standards to be requested by CSPI.
This article was originally published in The Tan Sheet
Executive Summary
GARLIC SUPPLEMENT POTENCY LABELING INFORMATION STANDARDS will be requested by the Center for Science in the Public Interest in an up-coming letter to FDA. The organization said it plans to seek labeling standards to address the fact that the wide divergence in potency among marketed garlic supplements is not currently reflected on product labeling. Potency differences were indicated in a CSPI-sponsored study on garlic supplements released July 31.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning